2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
4
Head and Neck Neoplasms
3
Polycystic Ovary Syndrome
2
Pain
2
Neoplasms
2
Endocrine System Diseases
2
Amenorrhea
2
Trismus
1
Thrombosis
1
Neuroma
1
Movement Disorders
1
Motor Activity
1
Lymphedema
1
Health Education
1
Fibrosis
1
Deglutition Disorders
1
Anxiety Disorders
1
Agnosia
1
Interventions
Blood Specimen Collection
8
Magnetic Resonance Spectroscopy
5
Pentoxifylline
4
Liver Transplantation
4
Tenofovir
3
Specimen Handling
3
High-Energy Shock Waves
3
Tocopherols
2
Sorafenib
2
Simvastatin
2
Low-Level Light Therapy
2
Gemcitabine
2
tremelimumab
1
sonidegib
1
sofosbuvir-velpatasvir drug combination
1
ruxolitinib
1
peginterferon alfa-2a
1
navitoclax
1
maltodextrin
1
hepatitis B hyperimmune globulin
1
esmolol
1
epigallocatechin gallate
1
durvalumab
1
contrast agent BR1
1
bavituximab
1
atezolizumab
1
apixaban
1
alpha-Tocopherol
1
adefovir dipivoxil
1
Viusid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Fibrosis
×
Musculoskeletal Manipulations
×
Clear all
NCT03612531
2026-04-23
MANTLE
M.D. Anderson Cancer Center
Phase NA
Active not recruiting
24 enrolled